Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Zens

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biomedicine Hub|December 1, 2025
Infection-Related Glomerulonephritis Revealed as Shunt Nephritis: A Case ReportNathalie Hammer, Antonio Rodriguez-Calero, Philipp Zens, et al.
Virchows Archiv : an International Journal of Pathology|December 5, 2024
Breaking barriers in pathology: bridging gaps in multidisciplinary collaborationRui Almeida, Ceren Boyaci, Marcin Braun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 22, 2024
Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability AssessmentMarie Maillard, Christina Neppl, Philipp Zens, et al.
Cells|October 23, 2021
Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant TherapyTereza Losmanova, Philipp Zens, Amina Scherz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 2022
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancerPhilipp Zens, Corina Bello, Amina Scherz, et al.
Oncoimmunology|February 10, 2025
Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinomaQian Wang, Na Sun, Chaoyang Zhang, et al.
NPJ Precision Oncology|November 3, 2023
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinomaJun Wang, Na Sun, Thomas Kunzke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 14, 2021
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological responsePhilipp Zens, Corina Bello, Amina Scherz, et al.
JTO Clinical and Research Reports|October 24, 2022
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 PatientsAlexandra Kündig, Philipp Zens, Christian Fung, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2021
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutationsErik Vassella, Elham Kashani, Philipp Zens, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biomedicine Hub|December 1, 2025
Infection-Related Glomerulonephritis Revealed as Shunt Nephritis: A Case ReportNathalie Hammer, Antonio Rodriguez-Calero, Philipp Zens, et al.
Virchows Archiv : an International Journal of Pathology|December 5, 2024
Breaking barriers in pathology: bridging gaps in multidisciplinary collaborationRui Almeida, Ceren Boyaci, Marcin Braun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 22, 2024
Multicenter Study on Tumor Budding in Lung Squamous Cell Carcinoma: Comparison Between Biopsy and Resection With Interobserver Variability AssessmentMarie Maillard, Christina Neppl, Philipp Zens, et al.
Cells|October 23, 2021
Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant TherapyTereza Losmanova, Philipp Zens, Amina Scherz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 2022
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancerPhilipp Zens, Corina Bello, Amina Scherz, et al.
Oncoimmunology|February 10, 2025
Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinomaQian Wang, Na Sun, Chaoyang Zhang, et al.
NPJ Precision Oncology|November 3, 2023
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinomaJun Wang, Na Sun, Thomas Kunzke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 14, 2021
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological responsePhilipp Zens, Corina Bello, Amina Scherz, et al.
JTO Clinical and Research Reports|October 24, 2022
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 PatientsAlexandra Kündig, Philipp Zens, Christian Fung, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2021
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutationsErik Vassella, Elham Kashani, Philipp Zens, et al.
Pageof 3